A1 Orlando Medical Corporation Consolidated Statements of Financial Position 1 December 31, 3 (In Millions) 2018 2017 Assets: Current Assets Cash and cash equivalents Short-term investments Accounts and notes receivable Inventories, at cost Prepaid expense and other current assets Total current assets $ 4,226 $ 4,333 845 6. 520 8. 3,400 433 2,403 411 1,226 10 1,638 10,649 1,555 6,804 303 $ 19,311 11 8,786 907 5,199 155 $ 15,047 12 Property and equipment, net 14 Other non-current assets 15 Total assets 16 Liabilities and stockholders' equity: Current liabilities Accounts payable Accrued and other liabilities 17 18 19 $ 7,708 3,676 11,384 304 1.701 13,389 $ 6,009 3,033 9,042 305 1.179 10,526 Total current liabilities 20 21 Long-term debt Other non-current liabilities 23 Total liabilities 24 Stockholders' equity 22 Preferred stock and capital in excess of $0.02 par value; 25 shares issued and outstanding: none Common stock and capital in excess of S0.05 par value; 28 26 27 shares authorized: 6,000; shares issued: 2,163 and 1,903, respectively Treasury stock, at cost: 183 and 123 shares, respectively 29 7,803 (6,444) 4,676 (79) (34) 5,922 $ 19,311 7,001 (4,401) 1,990 (25) (44) 4,521 $ 15,047 30 31 Retained earnings 32 Other comprehensive loss 33 Other 34 Total stockholders' equity 35 Total liabilities and stockholders' equity 36 A1 Orlando Medical Corporation Consolidated Statements of Income 2 Year ended December 31, 3 (In Millions, Except per Share Amounts) 4 Net Revenue 5 Cost of goods sold 2018 $ 42,666 35,147 7,519 2016 $ 31,111 25,492 5,619 2017 $ 35,220 29,255 5,965 Gross profit 7 Operating expenses: 8. 6. Selling, general, and administrative Research, development, and engineering 10 3,341 544 3,250 553 2,985 536 512 4,033 1,586 (30) 1,556 472 $ 1.084 Special charges Total operating expenses. Operating income 11 12 13 Investment and other income (loss), net 14 3,885 3,634 153 3,787 1.136 $ 2,651 3,803 2,162 196 2,358 940 $ 1.418 Income before income taxes 15 Income tax expense 16 Net income 17 Earnings per common share: Basic 19 1.41 0.95 $ 0.37
A1 Orlando Medical Corporation Consolidated Statements of Financial Position 1 December 31, 3 (In Millions) 2018 2017 Assets: Current Assets Cash and cash equivalents Short-term investments Accounts and notes receivable Inventories, at cost Prepaid expense and other current assets Total current assets $ 4,226 $ 4,333 845 6. 520 8. 3,400 433 2,403 411 1,226 10 1,638 10,649 1,555 6,804 303 $ 19,311 11 8,786 907 5,199 155 $ 15,047 12 Property and equipment, net 14 Other non-current assets 15 Total assets 16 Liabilities and stockholders' equity: Current liabilities Accounts payable Accrued and other liabilities 17 18 19 $ 7,708 3,676 11,384 304 1.701 13,389 $ 6,009 3,033 9,042 305 1.179 10,526 Total current liabilities 20 21 Long-term debt Other non-current liabilities 23 Total liabilities 24 Stockholders' equity 22 Preferred stock and capital in excess of $0.02 par value; 25 shares issued and outstanding: none Common stock and capital in excess of S0.05 par value; 28 26 27 shares authorized: 6,000; shares issued: 2,163 and 1,903, respectively Treasury stock, at cost: 183 and 123 shares, respectively 29 7,803 (6,444) 4,676 (79) (34) 5,922 $ 19,311 7,001 (4,401) 1,990 (25) (44) 4,521 $ 15,047 30 31 Retained earnings 32 Other comprehensive loss 33 Other 34 Total stockholders' equity 35 Total liabilities and stockholders' equity 36 A1 Orlando Medical Corporation Consolidated Statements of Income 2 Year ended December 31, 3 (In Millions, Except per Share Amounts) 4 Net Revenue 5 Cost of goods sold 2018 $ 42,666 35,147 7,519 2016 $ 31,111 25,492 5,619 2017 $ 35,220 29,255 5,965 Gross profit 7 Operating expenses: 8. 6. Selling, general, and administrative Research, development, and engineering 10 3,341 544 3,250 553 2,985 536 512 4,033 1,586 (30) 1,556 472 $ 1.084 Special charges Total operating expenses. Operating income 11 12 13 Investment and other income (loss), net 14 3,885 3,634 153 3,787 1.136 $ 2,651 3,803 2,162 196 2,358 940 $ 1.418 Income before income taxes 15 Income tax expense 16 Net income 17 Earnings per common share: Basic 19 1.41 0.95 $ 0.37
Chapter1: Financial Statements And Business Decisions
Section: Chapter Questions
Problem 1Q
Related questions
Question
Orlando Medical’s common-size income statement for 2018 would report cost of
goods sold as
a. 82.4%.
b. $35,147 million.
c. up by 20.1%.
d. 137.9%.
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
Step by step
Solved in 2 steps with 2 images
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, accounting and related others by exploring similar questions and additional content below.Recommended textbooks for you
Accounting
Accounting
ISBN:
9781337272094
Author:
WARREN, Carl S., Reeve, James M., Duchac, Jonathan E.
Publisher:
Cengage Learning,
Accounting Information Systems
Accounting
ISBN:
9781337619202
Author:
Hall, James A.
Publisher:
Cengage Learning,
Accounting
Accounting
ISBN:
9781337272094
Author:
WARREN, Carl S., Reeve, James M., Duchac, Jonathan E.
Publisher:
Cengage Learning,
Accounting Information Systems
Accounting
ISBN:
9781337619202
Author:
Hall, James A.
Publisher:
Cengage Learning,
Horngren's Cost Accounting: A Managerial Emphasis…
Accounting
ISBN:
9780134475585
Author:
Srikant M. Datar, Madhav V. Rajan
Publisher:
PEARSON
Intermediate Accounting
Accounting
ISBN:
9781259722660
Author:
J. David Spiceland, Mark W. Nelson, Wayne M Thomas
Publisher:
McGraw-Hill Education
Financial and Managerial Accounting
Accounting
ISBN:
9781259726705
Author:
John J Wild, Ken W. Shaw, Barbara Chiappetta Fundamental Accounting Principles
Publisher:
McGraw-Hill Education